Article first published online: 15 MAY 2013
Copyright © 2013 American Association for the Study of Liver Diseases
Volume 58, Issue 1, pages 182–191, July 2013
How to Cite
Park, Y.-Y., Kim, S.-B., Han, H. D., Sohn, B. H., Kim, J. H., Liang, J., Lu, Y., Rodriguez-Aguayo, C., Lopez-Berestein, G., Mills, G. B., Sood, A. K. and Lee, J.-S. (2013), Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520. Hepatology, 58: 182–191. doi: 10.1002/hep.26310
Potential conflict of interest: Dr. Mills consults for and received grants from Astra Zeneca. He consults for and owns stock in Catena Pharmaceuticals. He also consults for Critical Outcome Technologies, Daiichi, Targeted Molecular Diagnotics, Foundation Medicine, Han AlBio Korea, Komen Foundation, Novartis, Symphogen, and Tau Therapeutics. He owns stock in PTV Ventures and Spindle Top Ventures. He received grants from Celgene, CeMines, Exelixis/Sanofi, GlaxoSmithKline, Roche, and Wyether/Pfizer/Puma.
This research is supported, in part, by the 2011 and 2012 cycle of MD Anderson Sister Institute Network Fund (to J-S.L.), 5U54 CA112970-08 (to G.B.M.), 5P01CA099031-07 (to G.B.M.), P30 CA016672 (to G.B.M.), and CA016672 (MD Anderson Cancer Center Support Grant) from the National Institutes of Health.
- Issue published online: 24 JUN 2013
- Article first published online: 15 MAY 2013
- Accepted manuscript online: 6 FEB 2013 12:15PM EST
- Manuscript Accepted: 30 JAN 2013
- Manuscript Received: 23 OCT 2012